Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Mental health disorders

Low vitamin D levels linked to depression and cognitive deficits in psychotic disorders

Study shows a link between vitamin D and depression, while vitamin D deficiency was linked to impairments in processing speed and verbal fluency.

Previous research has shown that low vitamin D levels may be associated with increased disease severity in psychotic disorders.

To explore which symptoms are affected by vitamin D status, a team from the Norwegian Centre for Mental Disorders Research recruited 358 patients and compared their vitamin D levels against measures of symptom severity.

The researchers found that low vitamin D levels were significantly associated with negative symptoms and depression. When they studied the performance of 225 patients alongside 159 healthy controls in cognitive function tests, vitamin D deficiency was also linked to impairments in processing speed and verbal fluency.

The team, who reported their findings at the International Early Psychosis Association Meeting in Milan in October 2016[1], say the results show the need for large randomised trials to explore any potential benefit of vitamin D in psychotic disorders.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20201899

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.